PPP1CA and breast carcinoma: Among these, ABCC3, ACPP, PPP1CA, PRKAG3, and RNASEL exhibited interactions with several proteins, immune checkpoint markers, and chemotherapeutic drugs administered in both human breast cancer and FMC (Fig 5).